US Stocks
/
enGene Therapeutics Inc. Share Price

enGene Therapeutics Inc. Share Price

NASDAQ: ENGN
$1.79
-$0.00 (-0.28%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

enGene Therapeutics Inc. Stock Performance

Open
$1.81
Prev. Close
$1.79
Circuit Range
N/A
Day Range
$1.79 - $1.83
Year Range
$1.41 - $12.25
Volume
39,123
Average Traded
$1.81

enGene Therapeutics Inc. Share Price Today

As of 10 August 2026, enGene Therapeutics Inc.'s share price is $1.79. The stock opened at $1.81, compared to its previous close of $1.79. During today's trading session, enGene Therapeutics Inc.'s share price traded between $1.79 and $1.83, with an average price of $1.81. Over the past 52 weeks, the stock has recorded a high of $12.25 and a low of $1.41. In terms of performance, enGene Therapeutics Inc.'s share price has declined by 82.15% over the last six months and is down 61.09% on a year-on-year basis.

enGene Therapeutics Inc. Share Price Chart

$1.79$1.83
L
Show Current Price
H

enGene Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsApr 2024Jul 2024Jan 2025Apr 2025Jul 2025Jan 2026
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$14.98M-$14.15M-$24.62M-$25.82M-$28.99M-$29.75M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A5.58%-73.99%-4.87%-12.30%-2.62%

enGene Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2023
RevenueN/A
Net Profit-$99.92M
Net Profit MarginN/A
Income ChangeN/A

About enGene Therapeutics Inc.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.

enGene Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.76
$1.79
+0.00%
Jul 2026
$1.74
$1.79
+2.29%
Jun 2026
$1.81
$1.75
-4.89%
May 2026
$7.29
$1.84
-74.79%
Apr 2026
$6.96
$7.30
+7.51%
Mar 2026
$9.96
$6.79
-32.30%
Feb 2026
$9.55
$10.03
+5.19%
Jan 2026
$8.86
$9.54
+6.18%
Dec 2025
$7.83
$8.98
+11.84%
Nov 2025
$7.41
$8.03
+9.76%
Oct 2025
$6.97
$7.32
+9.34%
Sep 2025
$4.69
$6.69
+45.43%

ENGN Share Price FAQs

What is enGene Therapeutics Inc. share price today?

chevron-up
enGene Therapeutics Inc. share price today is $1.79 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of enGene Therapeutics Inc. stock?

chevron-up
The 52 week high of enGene Therapeutics Inc. stock is $12.25, while the 52 week low is $1.41 as of 8 Aug '26.

What is ENGN's net income for the last quarter?

chevron-up
ENGN's net income for the last quarter is -0.03B USD.

What is the 5 year returns of ENGN?

chevron-up
The 5 year returns of ENGN is -81.92% as on 8 Aug '26.

What is the high & low stock price of ENGN today?

chevron-up
ENGN stock price hit a high of $1.83 and low of $1.79 as of 8 Aug '26.

Can I buy ENGN shares in India?

chevron-up
Yes. You can buy ENGN in India by opening an international trading account.